Physician profile
Ramon D Espinal
NPI 1851390363
$5,523.41
in general payments reported to CMS, 2019-2025
35 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,202 · 2020: $468 · 2021: $707 · 2022: $990 · 2023: $137 · 2024: $798 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,045.39 | 2019-2022 | |
| Abbott Laboratories | $926.48 | 2019-2022 | |
| Boston Scientific Corporation | $524.82 | 2019-2024 | Intracept |
| Si-Bone, INC. | $435.84 | 2019-2021 | |
| Medtronic, INC. | $387.49 | 2023-2024 | Intellis Adaptivestim |
| Stimwave Technologies Incorporated | $289.87 | 2019-2022 | |
| Forte Bio-Pharma LLC | $283.01 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $270.15 | 2019-2023 | Xtampza |
| Medtronic USA, INC. | $196.82 | 2019-2020 | |
| Vertiflex, INC. | $172.99 | 2019 | |
| Stryker Corporation | $150.00 | 2024 | Mild Device Kit |
| Curonix LLC | $107.90 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.98 | 2019-2024 | Relistor |
| Radius Health, INC. | $83.46 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $63.12 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $56.36 | 2019 | |
| Relievant Medsystems, INC. | $50.14 | 2022-2023 | Intracept |
| Amgen INC. | $40.47 | 2020-2021 | |
| Horizon Therapeutics Plc | $36.49 | 2021 | |
| Scilex Pharmaceuticals INC. | $35.10 | 2021 | |
| Virtus Pharmaceuticals LLC | $26.64 | 2021 | |
| Vertical Pharmaceuticals, LLC | $26.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.96 | 2019 | |
| Trevena, INC. | $24.67 | 2022 | |
| Shionogi INC | $21.16 | 2019 | |
| Nalu Medical, INC. | $20.24 | 2020 | |
| Masimo Corporation | $18.74 | 2023 | Patient Safetynet System |
| Valinor Pharma, LLC | $18.19 | 2025 | Movantik |
| Kaleo, INC. | $16.82 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $15.05 | 2021 | |
| Assertio Therapeutics, INC. | $14.60 | 2019 | |
| Mdd US Operations, LLC | $14.45 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.80 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $12.43 | 2019 | |
| Pfizer INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Espinal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.